Germany · Delayed Price · Currency is EUR Pentixapharm Holding AG Statistics
Total Valuation
ETR:PTP has a market cap or net worth of EUR 46.89 million. The enterprise value is 42.27 million.
| Market Cap | 46.89M |
| Enterprise Value | 42.27M |
Important Dates
The last earnings date was Thursday, March 26, 2026.
| Earnings Date | Mar 26, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ETR:PTP has 24.78 million shares outstanding.
| Current Share Class | 24.78M |
| Shares Outstanding | 24.78M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 0.20% |
| Owned by Institutions (%) | 6.66% |
| Float | 15.24M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 73.73 |
| PB Ratio | 1.34 |
| P/TBV Ratio | 16.81 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -2.56 |
| EV / Sales | 66.46 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -2.27 |
Financial Position
The company has a current ratio of 1.73
| Current Ratio | 1.73 |
| Quick Ratio | 1.40 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -39.09% and return on invested capital (ROIC) is -29.38%.
| Return on Equity (ROE) | -39.09% |
| Return on Assets (ROA) | -22.72% |
| Return on Invested Capital (ROIC) | -29.38% |
| Return on Capital Employed (ROCE) | -51.72% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 9,938 |
| Profits Per Employee | -257,984 |
| Employee Count | 64 |
| Asset Turnover | 0.01 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -3.00M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -43.27% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -43.27% |
| 50-Day Moving Average | 1.98 |
| 200-Day Moving Average | 1.83 |
| Relative Strength Index (RSI) | 46.65 |
| Average Volume (20 Days) | 7,936 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, ETR:PTP had revenue of EUR 636,000 and -16.51 million in losses. Loss per share was -0.67.
| Revenue | 636,000 |
| Gross Profit | -6.16M |
| Operating Income | -19.86M |
| Pretax Income | -19.51M |
| Net Income | -16.51M |
| EBITDA | -16.13M |
| EBIT | -19.86M |
| Loss Per Share | -0.67 |
Balance Sheet
The company has 4.62 million in cash and n/a in debt, with a net cash position of 4.62 million or 0.19 per share.
| Cash & Cash Equivalents | 4.62M |
| Total Debt | n/a |
| Net Cash | 4.62M |
| Net Cash Per Share | 0.19 |
| Equity (Book Value) | 35.07M |
| Book Value Per Share | 1.42 |
| Working Capital | 2.53M |
Cash Flow
In the last 12 months, operating cash flow was -17.97 million and capital expenditures -625,000, giving a free cash flow of -18.60 million.
| Operating Cash Flow | -17.97M |
| Capital Expenditures | -625,000 |
| Depreciation & Amortization | 3.73M |
| Net Borrowing | n/a |
| Free Cash Flow | -18.60M |
| FCF Per Share | -0.75 |
Margins
| Gross Margin | n/a |
| Operating Margin | -3,122.64% |
| Pretax Margin | -3,068.08% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ETR:PTP does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -35.21% |
| FCF Yield | -39.66% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |